Roth CH Acquisition III Co.
Status: Deal Closed
U=S+W/4
W=S@11.5
| IPO Proceeds, $M | $115.00M |
|---|---|
| IPO Date | Mar 3, 2021 |
| CEO | Byron Roth |
| Left Lead | Roth Capital Partners |
| IPO Cash in Trust | 100.0% |
| SPAC Tenor | 24 months |
| IPO Sector |
General
Business services, consumer, healthcare, technology, wellness or sustainability |
| IPO Geography | Global |
| Target Company | QualTek |
| Deal Announced | Jun 16, 2021 |
| Deal Size, $M | $828.70M |
| Deal Sector | Technology |
| Deal Geography | US/Canada |
| SEC Filings | www.sec.gov |
| Approval Vote | Feb 14, 2022 |
| Amendment Vote | TBD |
| Closing Date | Feb 14, 2022 |
Formerly ROCR
QTEKQ
QTEKW
| Price | |
|---|---|
| Volume, 3-month avg. | N/A |
Sign up for Free Trial
No credit card required
Sign in for more on Roth CH Acquisition III Co.:
- Structure and cap table
- 10 directors & officers
- 32 filings and events
- 2 underwriters
- 4 deal advisors
- 2 legal advisors
Structure
Sign in to view structure, cap table, and calendar of events.
Team
| Name | Age | Title |
|---|---|---|
| Byron Roth | 58 | CEO and Chairman |
| Gordon Roth | 66 | CFO |
| Rick Hartfiel | 56 | Co-President |
| John Lipman | 44 | COO and Director |
| Aaron Gurewitz | 52 | Co-President |
| James Gold | 56 | Director |
| Molly Hemmeter | 54 | Director |
| Daniel M. Friedberg | 59 | Director |
| Adam Rothstein | 49 | Director |
| Sam Chawla | Director |
Sign in to view team biographies and more sponsor and affiliate data.
Advisors
Underwriters
| Roth Capital Partners | Joint BR | 5,000,000 | units |
| Craig-Hallum Capital Group | Joint BR | 5,000,000 | |
| 10,000,000 | units | ||
| Up-Front UW fee | 2.00 | % | |
| BCMA | 3.50 | % |
Sign in to view more advisor data.
Deal
Sign in to view merger details and deal financials.